Clinical trials: Peyronie Disease, active
Peyronie Disease, Erectile Dysfunction
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
The purpose of this research is to determine whether or not low-intensity shockwave therapy (LiSWT) with Xiaflex treatment will result in greater improvements to the curvature of the penis.
- Trial name
- NCT06065436
- Testing
- Collagenase Clostridium Histolyticum, Storz Duolith LiSWT
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Mayo Clinic
Peyronie Disease
Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease
Our team has previously demonstrated efficacy in performing a novel collagenase Clostridium histolyticum (CCH) injection protocol in men who previously failed to achieve a response to an initial 4 series of CCH.
- Trial name
- NCT06649539
- Testing
- Collagenase Clostridium Histolyticum, RestoreX, Sildenafil
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- Charitable Union for the Research and Education of Peyronie's Disease
Peyronie Disease, Sexual Dysfunctions, Psychological
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease
The purpose of this study is to learn about the safety and side effects of intralesional collagenase clostridium histolyticum (CCH) injected into the Peyronies Disease (PD) plaque after receiving prior treatment with…
- Conditions
- Peyronie Disease, Sexual Dysfunctions, Psychological, Genital Diseases, Male
- Trial name
- NCT05777031
- Testing
- Collagenase Clostridium Histolyticum (CCH)
- Where
- 2 sites in United States
- Volunteers
- 12 people
- Sponsor
- University of Miami
Peyronie Disease
Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease
Investigation of the effectiveness of extracorporeal shock wave therapy in the treatment of Peyronie's disease.
- Trial name
- NCT07317297
- Testing
- Extracorporeal Shockwave Therapy, control
- Where
- Azerbaijan
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Uskudar University
Peyronie Disease
Pilot Study on the Efficacy and Safety of FIBRORESTIL® as an Adjuvant Intralesional Treatment in Patients With Peyronie's Disease Receiving Standard Therapy
Peyronie's disease is a connective tissue disorder of the penis characterized by the formation of fibrous plaques in the tunica albuginea, leading to penile curvature, possible erectile dysfunction, and significant physical and…
- Trial name
- FIBRONIE (NCT07341529)
- Testing
- Intralesional hyaluronic acid-based enzymatic medical device, Standard conservative treatment for Peyronie's disease
- Where
- 2 sites in Spain
- Volunteers
- 38 people
- Sponsor
- Lyx Institute
Peyronie's Disease
Microneedle Treatment of Chronic Phase Peyronie's Disease: A Pilot Clinical Trial
Peyronie's Disease (PD) is a disorder of the penis where scar tissue (composed of excessive and disorganized collagen) known as a "plaque," forms along the shaft of the penis.
- Trial name
- NCT07128420
- Testing
- Application of 3 sessions of microneedle therapy
- Where
- Canada
- Volunteers
- 10 people
- Sponsor
- Ottawa Hospital Research Institute
Peyronie Disease, Penile Curvature
Platelet-Rich Plasma Injections From Cord Blood + Penile Traction vs. Penile Traction Alone in Patients With Peyronie's Disease. Open-label, Single-center Randomized Study
The goal of this clinical trial is to learn if Platelet-Rich Plasma Injections from Cord Blood (CB-PRP) is useful in Peyronie disease.
- Conditions
- Peyronie Disease, Penile Curvature, PRP Injection, Cord Blood
- Trial name
- CB-PRP-TRAC1 (NCT07010900)
- Testing
- Injection
- Where
- Italy
- Volunteers
- 42 people
- Sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico